SENATE
HOUSE
JOINT
BILL STATUS
WV CODE
REPORTS
EDUCATIONAL
CONTACT
home
home

West Virginia Code

Search

Chapter 16     Entire Code
‹ Chapter 15  |  Chapter 17 › Printer Friendly Versions
Chapter 16  |  Article 16 - 51

1 - STATE PUBLIC HEALTH SYSTEM

1A - UNIFORM CREDENTIALING FOR HEAL

1B - SKILLED NURSING FACILITIES FOR

1C - HEALTH CARE PROVIDER TRANSPARE

2 - LOCAL BOARDS OF HEALTH

2A - ALTERNATIVE METHOD OF ORGANIZI

2B - FAMILY PLANNING AND CHILD SPAC

2C - HOME HEALTH SERVICES

2D - CERTIFICATE OF NEED

2E - BIRTHING CENTERS

2F - PARENTAL NOTIFICATION OF ABORT

2G - SPECIAL SUPPLEMENTARY FOOD PRO

2H - PRIMARY CARE SUPPORT PROGRAM

2I - WOMEN'S RIGHT TO KNOW ACT

2J - PREVENTIVE CARE PILOT PROGRAM

2K - PROGRAMS OF ALL-INCLUSIVE CARE

2L - PROVIDER SPONSORED NETWORKS

2M - THE PAIN CAPABLE UNBORN CHILD

2N - NEONATAL ABSTINENCE CENTERS

2O - UNBORN CHILD PROTECTION FROM

3 - PREVENTION AND CONTROL OF COMMU

3A - REPOSITORY OF INFORMATION ON M

3B - PERTUSSIS

3C - AIDS-RELATED MEDICAL TESTING A

3D - TUBERCULOSIS TESTING, CONTROL,

4 - SEXUALLY TRANSMITTED DISEASES

4A - PRENATAL EXAMINATION

4B - AUTOPSIES ON BODIES OF DECEASE

4C - EMERGENCY MEDICAL SERVICES ACT

4D - AUTOMATED EXTERNAL DEFIBRILLAT

4E - UNIFORM MATERNAL SCREENING ACT

4F - EXPEDITED PARTNER THERAPY

5 - VITAL STATISTICS

5A - CANCER CONTROL

5B - HOSPITALS AND SIMILAR INSTITUT

5C - NURSING HOMES

5D - ASSISTED LIVING RESIDENCES

5E - REGISTRATION AND INSPECTION OF

5F - HEALTH CARE FINANCIAL DISCLOSU

5G - OPEN HOSPITAL PROCEEDINGS

5H - CHRONIC PAIN CLINIC LICENSING

5I - HOSPICE LICENSURE ACT

5J - CLINICAL LABORATORIES QUALITY

5K - EARLY INTERVENTION SERVICES FO

5L - LONG-TERM CARE OMBUDSMAN PROGR

5M - OSTEOPOROSIS PREVENTION EDUCAT

5N - RESIDENTIAL CARE COMMUNITIES

5O - MEDICATION ADMINISTRATION BY U

5P - SENIOR SERVICES

5Q - THE JAMES TIGER MORTON CATASTR

5R - THE ALZHEIMER'S SPECIAL CARE S

5S - OLDER WEST VIRGINIANS ACT

5T - CARE HOME ADVISORY BOARD

5U - ARTHRITIS PREVENTION EDUCATION

5V - EMERGENCY MEDICAL SERVICES RET

5W - WEST VIRGINIA OFFICIAL PRESCRI

5X - CAREGIVER ADVISE, RECORD AND E

5Y - MEDICATION-ASSISTED TREATMENT

6 - HOTELS AND RESTAURANTS

7 - PURE FOOD AND DRUGS

8 - ELECTROLOGISTS

8A - NARCOTIC DRUGS

8B - DANGEROUS DRUGS ACT

9 - OFFENSES GENERALLY

9A - TOBACCO USAGE RESTRICTIONS

9B - IMPLEMENTING TOBACCO MASTER SE

9C - STATE TOBACCO GROWERS' SETTLEM

9D - ENFORCEMENT OF STATUTES IMPLEM

9E - DELIVERY SALES OF TOBACCO

9F - COUNTERFEIT CIGARETTES

10 - UNIFORM DETERMINATION OF DEAT

11 - SEXUAL STERILIZATION

12 - SANITARY DISTRICTS FOR SEWAGE

13 - SEWAGE WORKS AND STORMWATER W

13A - PUBLIC SERVICE DISTRICTS

13B - COMMUNITY IMPROVEMENT ACT

13C - DRINKING WATER TREATMENT REV

13D - REGIONAL WATER AND WASTEWATE

13E - COMMUNITY ENHANCEMENT ACT

14 - BARBERS AND COSMETOLOGISTS

15 - STATE HOUSING LAW

16 - HOUSING COOPERATION LAW

17 - NATIONAL DEFENSE HOUSING

18 - SLUM CLEARANCE

19 - ANATOMICAL GIFT ACT

20 - AIR POLLUTION CONTROL

21 - BLOOD DONATIONS

22 - DETECTION AND CONTROL OF PHEN

22A - TESTING OF NEWBORN INFANTS F

22B - BIRTH SCORE PROGRAM

23 - TRANSFUSION OF BLOOD; TRANSPL

24 - STATE HEMOPHILIA PROGRAM

25 - DETECTION OF TUBERCULOSIS, HI

26 - WEST VIRGINIA SOLID WASTE MAN

27 - STORAGE AND DISPOSAL OF RADIO

27A - BAN ON CONSTRUCTION OF NUCLE

28 - ASSISTANCE TO KOREAN AND VIET

29 - HEALTH CARE RECORDS

29A - WEST VIRGINIA HOSPITAL FINAN

29B - HEALTH CARE AUTHORITY

29C - INDIGENT CARE

29D - STATE HEALTH CARE

29E - LEGISLATIVE OVERSIGHT COMMIS

29F - UNINSURED AND UNDERINSURED P

29G - WEST VIRGINIA HEALTH INFORMA

29H - INTERAGENCY HEALTH COUNCIL

29I - WEST VIRGINIA HEALTH CARE AU

30 - WEST VIRGINIA HEALTH CARE DEC

30A - MEDICAL POWER OF ATTORNEY

30B - HEALTH CARE SURROGATE ACT

30C - DO NOT RESUSCITATE ACT

31 - COMMUNITY RIGHT TO KNOW

32 - ASBESTOS ABATEMENT

33 - BREAST AND CERVICAL CANCER PR

34 - LICENSURE OF RADON MITIGATORS

35 - LEAD ABATEMENT

36 - NEEDLESTICK INJURY PREVENTION

37 - BODY PIERCING STUDIO BUSINESS

38 - TATTOO STUDIO BUSINESS

39 - PATIENT SAFETY ACT

40 - STATEWIDE BIRTH DEFECTS INFOR

41 - ORAL HEALTH IMPROVEMENT ACT

42 - COMPREHENSIVE BEHAVIORAL HEAL

43 - ENGINE COOLANT AND ANTIFREEZE

44 - THE PULSE OXIMETRY NEWBORN TE

45 - TANNING FACILITIES

46 - ACCESS TO OPIOID ANTAGONISTS

47 - ALCOHOL AND DRUG OVERDOSE PRE

48 - WEST VIRGINIA ABLE ACT

49 - WEST VIRGINIA CLEARANCE FOR A

50 - EPINEPHRINE AUTO-INJECTOR AVA

51 - RIGHT TO TRY ACT
    16 - 51 - 1
    16 - 51 - 2
    16 - 51 - 3
    16 - 51 - 4
    16 - 51 - 5
    16 - 51 - 6
    16 - 51 - 7
    16 - 51 - 8

WVC 16-
CHAPTER 16. PUBLIC HEALTH.

WVC 16-51- ARTICLE 51. RIGHT TO TRY ACT.

WVC 16-51-1

§16-51-1.  Short title.

This article shall be known and may be cited as the Ben Price Right to Try Act.

WVC 16-51-2

§16-51-2.  Legislative findings.

(a) The Legislature finds and declares that:

(1) The process of approval for investigational drugs, biological products and devices in the United States protects future patients from premature, ineffective and unsafe medications and treatments over the long run, but the process often takes many years;

(2) Patients who have a terminal illness do not have the luxury of waiting until an investigational drug, biological product or device receives final approval from the United States Food and Drug Administration;

(3) Patients who have a terminal illness have a fundamental right to attempt to pursue the preservation of their own lives by accessing available investigational drugs, biological products and devices;

(4) The use of available investigational drugs, biological products and devices is a decision that should be made by the patient with a terminal illness in consultation with the patient’s health care provider and the patient’s health care team, if applicable; and

(5) The decision to use an investigational drug, biological product or device should be made with full awareness of the potential risks, benefits and consequences to the patient and the patient’s family.

(b) It is the intent of the Legislature to allow for terminally ill patients to use potentially life-saving or pain-relieving investigational drugs, biological products and devices.

WVC 16-51-3

§16-51-3.  Definitions.

For the purposes of this article:

(1) “Eligible patient” means a person who has:

(A) A terminal illness attested to by the patient’s treating physician;

(B) Considered all other treatment options currently approved by the United States Food and Drug Administration;

(C) Been unable to participate in a clinical trial for the terminal illness within one hundred miles of the patient’s home address for the terminal illness, or not been accepted to the clinical trial within one week of completion of the clinical trial application process;

(D) Received a recommendation from his or her physician for an investigational drug, biological product or device;

(E) Given written, informed consent for the use of the investigational drug, biological product or device or, if the patient is a minor or lacks the mental capacity to provide informed consent, a parent or legal guardian has given written, informed consent on the patient’s behalf; and

(F) Documentation from his or her physician that he or she meets the requirements of this subdivision.

(2) “Eligible patient” does not include a person being treated as an inpatient in a hospital licensed or certified pursuant to article five-b, chapter sixteen of this code.

(3) “Investigational drug, biological product or device” means a drug, biological product or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States Food and Drug Administration.

(4) “Terminal illness” means a disease that, without life-sustaining procedures, will soon result in death or a state of permanent unconsciousness from which recovery is unlikely.

(5) “Written, informed consent” means a written document signed by the patient and attested to by the patient’s physician and a witness that, at a minimum:

(A) Explains the currently approved products and treatments for the disease or condition from which the patient suffers;

(B) Attests to the fact that the patient concurs with his or her physician in believing that all currently approved and conventionally recognized treatments are unlikely to prolong the patient’s life;

(C) Clearly identifies the specific proposed investigational drug, biological product or device that the patient is seeking to use;

(D) Describes the potentially best and worst outcomes of using the investigational drug, biological product or device with a realistic description of the most likely outcome, including the possibility that new, unanticipated, different or worse symptoms might result and that death could be hastened by the proposed treatment based on the physician’s knowledge of the proposed treatment in conjunction with an awareness of the patient’s condition;

(E) Makes clear that the patient’s health insurer and provider may not be obligated to pay for any care or treatments consequent to the use of the investigational drug, biological product or device;

(F) Makes clear that the patient’s eligibility for hospice care may be withdrawn if the patient begins curative treatment and care may be reinstated if the curative treatment ends and the patient meets hospice eligibility requirements;

(G) Makes clear that in-home health care may be denied if treatment begins; and

(H) States that the patient understands that he or she may be liable for all expenses consequent to the use of the investigational drug, biological product or device, and that this liability extends to the patient’s estate, unless a contract between the patient and the manufacturer of the drug, biological product or device states otherwise.

WVC 16-51-4

§16-51-4.  Drug manufacturers; availability of investigational drugs, biological products or devices; costs; insurance coverage.

(a) A manufacturer of an investigational drug, biological product or device may make available the manufacturer’s investigational drug, biological product or device to eligible patients pursuant to this article. This article does not require that a manufacturer make available an investigational drug, biological product or device to an eligible patient.

(b) A manufacturer may:

(1) Provide an investigational drug, biological product or device to an eligible patient without receiving compensation; or

(2) Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product or device.

(c) Nothing in this article expands the coverage required by article fifteen, chapter thirty-three of this code.

(d) A health insurance carrier may, but is not required by this article to, provide coverage for the cost of an investigational drug, biological product or device.

(e) An insurer may deny coverage to an eligible patient from the time the eligible patient begins use of the investigational drug, biologic product or device through a period not to exceed six months from the time the investigational drug, biologic product or device is no longer used by the eligible patient; except that coverage may not be denied for a preexisting condition and for coverage for benefits which commenced prior to the time the eligible patient begins use of such drug, biologic product or device.

(f) If a patient dies while being treated by an investigational drug, biological product or device, the patient’s heirs and estate are not liable for any outstanding debt related to the treatment or lack of insurance due to the treatment.

WVC 16-51-5

§16-51-5.  Action against health care providers license or Medicare certification prohibited.

Notwithstanding any other law, a licensing board may not revoke, fail to renew, suspend or take any action against a health care provider’s license issued pursuant to chapter thirty of this code based solely on the health care provider’s recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product or device as long as the recommendations are consistent with medical standards of care.  Action against a health care provider’s Medicare certification based solely on the health care provider’s recommendation that a patient have access to an investigational drug, biological product or device is prohibited.

WVC 16-51-6

§16-51-6.  Access to investigational drugs, biological products and devices.

An official, employee or agent of this state shall not block or attempt to block an eligible patient’s access to an investigational drug, biological product or device.  Counseling, advice or a recommendation consistent with medical standards of care from a licensed health care provider is not a violation of this section.

WVC 16-51-7

§16-51-7.  No cause of action created.

This article does not create a private cause of action against a manufacturer of an investigational drug, biological product or device, against a health care provider as defined in section two, article seven-b, chapter fifty-five of this Code, or against any other person or entity involved in the care of an eligible patient using the investigational drug, biological product or device, for any harm done to the eligible patient resulting from the investigational drug, biological product or device, so long as the manufacturer, health care provider, or other person or entity is complying in good faith with the terms of this article.

WVC 16-51-8

§16-51-8.  Effect on health care coverage.

Nothing in this article affects the mandatory health care coverage for participation in clinical trials pursuant to section two, article twenty-five-f, chapter thirty-three of this code.

Note: WV Code updated with legislation passed through the 2016 Regular Session
The West Virginia Code Online is an unofficial copy of the annotated WV Code, provided as a convenience. It has NOT been edited for publication, and is not in any way official or authoritative.


Recent legislation affecting the Code

Citation Year/Session Short Title
§16 - 28 - 1 - (Repealed Code)
§16 - 28 - 2 - (Repealed Code)
§16 - 28 - 3 - (Repealed Code)
§16 - 28 - 4 - (Repealed Code)
§16 - 28 - 5 - (Repealed Code)
§16 - 28 - 6 - (Repealed Code)
§16 - 28 - 7 - (Repealed Code)
§16 - 28 - 8 - (Repealed Code)
§16 - 28 - 9 - (Repealed Code)
§16 - 28 - 10 - (Repealed Code)
SENATE BILL - 169
PASSED - Regular Session

sb169 enr  (Uploaded - 04/06/2017)
Repealing article providing assistance to Korea and Vietnam veterans exposed to certain chemical defoliants
§16 - 24 - 1 - (Repealed Code)
§16 - 24 - 2 - (Repealed Code)
§16 - 24 - 3 - (Repealed Code)
§16 - 24 - 4 - (Repealed Code)
§16 - 24 - 5 - (Repealed Code)
§16 - 24 - 6 - (Repealed Code)
§16 - 24 - 7 - (Repealed Code)
SENATE BILL - 170
PASSED - Regular Session

sb170 enr  (Uploaded - 04/06/2017)
Repealing state hemophilia program
§16 - 2 K- 1 - (Repealed Code)
§16 - 2 K- 2 - (Repealed Code)
SENATE BILL - 171
PASSED - Regular Session

sb171 enr  (Uploaded - 04/06/2017)
Repealing Programs of All-Inclusive Care for Elderly
§16 - 25 - 1 - (Repealed Code)
§16 - 25 - 2 - (Repealed Code)
§16 - 25 - 3 - (Repealed Code)
§16 - 25 - 4 - (Repealed Code)
SENATE BILL - 176
PASSED - Regular Session

sb176 enr  (Uploaded - 03/14/2017)
Repealing article concerning detection of tuberculosis, high blood pressure and diabetes
§16 - 5 Y- 2 - (Amended Code)
SENATE BILL - 188
PASSED - Regular Session

sb188 enr  (Uploaded - 03/14/2017)
Correcting definition of "telehealth" in medication-assisted treatment programs
§16 - 52 - 1 - (New Code)
§16 - 52 - 2 - (New Code)
§16 - 52 - 3 - (New Code)
§16 - 52 - 4 - (New Code)
§16 - 52 - 5 - (New Code)
SENATE BILL - 339
PASSED - Regular Session

SB339 SUB2 enr  (Uploaded - 04/28/2017)
Creating Legislative Coalition on Chronic Pain Management
§16 - 5 Z- 1 - (New Code)
§16 - 5 Z- 2 - (New Code)
§16 - 5 Z- 3 - (New Code)
§16 - 5 Z- 4 - (New Code)
§16 - 5 Z- 5 - (New Code)
SENATE BILL - 360
PASSED - Regular Session

SB360 SUB2 enr  (Uploaded - 04/14/2017)
Creating Legislative Coalition on Diabetes Management
§16 - 29 - 1 - (Amended Code)
§16 - 29 - 2 - (Amended Code)
SENATE BILL - 578
PASSED - Regular Session

sb578 enr  (Uploaded - 04/14/2017)
Relating generally to copies of health care records furnished to patients
§16 - 2 F- 1 - (Amended Code)
§16 - 2 F- 2 - (Amended Code)
§16 - 2 F- 3 - (Amended Code)
§16 - 2 F- 4 - (Amended Code)
§16 - 2 F- 5 - (Amended Code)
§16 - 2 F- 6 - (Amended Code)
§16 - 2 F- 8 - (Amended Code)
HOUSE BILL - 2002
PASSED - Regular Session

HB2002 SUB ENR  (Uploaded - 04/14/2017)
Relating to parental notification of abortions performed on unemancipated minors
§16 - 2 J- 1 - (Repealed Code)
§16 - 2 J- 2 - (Repealed Code)
§16 - 2 J- 3 - (Repealed Code)
§16 - 2 J- 4 - (Repealed Code)
§16 - 2 J- 5 - (Repealed Code)
§16 - 2 J- 6 - (Repealed Code)
§16 - 2 J- 7 - (Repealed Code)
§16 - 2 J- 8 - (Repealed Code)
§16 - 2 J- 9 - (Repealed Code)
HOUSE BILL - 2301
PASSED - Regular Session

HB2301 SUB ENR  (Uploaded - 03/20/2017)
Relating to direct primary care
§16 - 53 - 1 - (New Code)
§16 - 53 - 2 - (New Code)
§16 - 53 - 3 - (New Code)
HOUSE BILL - 2428
PASSED - Regular Session

HB2428 SUB ENR  (Uploaded - 04/17/2017)
Establishing additional substance abuse treatment facilities
§16 - 3 - 4 A - (New Code)
HOUSE BILL - 2431
PASSED - Regular Session

hb2431 ENR  (Uploaded - 03/20/2017)
Allowing influenza immunizations to be offered to patients and residents of specified facilities
§16 - 2 D- 2 - (Amended Code)
§16 - 2 D- 3 - (Amended Code)
§16 - 2 D- 4 - (Amended Code)
§16 - 2 D- 5 - (Amended Code)
§16 - 2 D- 5 F - (Repealed Code)
§16 - 2 D- 8 - (Amended Code)
§16 - 2 D- 9 - (Amended Code)
§16 - 2 D- 10 - (Amended Code)
§16 - 2 D- 11 - (Amended Code)
§16 - 2 D- 13 - (Amended Code)
§16 - 2 D- 15 - (Amended Code)
§16 - 2 D- 16 - (Amended Code)
§16 - 5 B- 17 - (Amended Code)
§16 - 5 F- 1 - (Repealed Code)
§16 - 5 F- 2 - (Repealed Code)
§16 - 5 F- 3 - (Repealed Code)
§16 - 5 F- 4 - (Repealed Code)
§16 - 5 F- 5 - (Repealed Code)
§16 - 5 F- 6 - (Repealed Code)
§16 - 5 F- 7 - (Repealed Code)
§16 - 29 B- 2 - (Amended Code)
§16 - 29 B- 3 - (Amended Code)
§16 - 29 B- 5 - (Amended Code)
§16 - 29 B- 5 A - (New Code)
§16 - 29 B- 6 - (Repealed Code)
§16 - 29 B- 7 - (Repealed Code)
§16 - 29 B- 8 - (Amended Code)
§16 - 29 B- 9 - (Repealed Code)
§16 - 29 B- 10 - (Repealed Code)
§16 - 29 B- 11 - (Repealed Code)
§16 - 29 B- 12 - (Amended Code)
§16 - 29 B- 17 - (Repealed Code)
§16 - 29 B- 18 - (Repealed Code)
§16 - 29 B- 22 - (Repealed Code)
§16 - 29 B- 23 - (Repealed Code)
§16 - 29 B- 24 - (Repealed Code)
§16 - 29 B- 25 - (Repealed Code)
§16 - 29 B- 26 - (Amended Code)
§16 - 29 B- 27 - (Repealed Code)
§16 - 29 B- 28 - (Amended Code)
§16 - 29 B- 29 - (Repealed Code)
§16 - 29 B- 30 - (New Code)
§16 - 29 G- 1 A - (New Code)
§16 - 29 G- 4 - (Amended Code)
§16 - 29 I- 1 - (Repealed Code)
§16 - 29 I- 2 - (Repealed Code)
§16 - 29 I- 3 - (Repealed Code)
§16 - 29 I- 4 - (Repealed Code)
§16 - 29 I- 5 - (Repealed Code)
§16 - 29 I- 6 - (Repealed Code)
§16 - 29 I- 7 - (Repealed Code)
§16 - 29 I- 8 - (Repealed Code)
§16 - 29 I- 9 - (Repealed Code)
§16 - 29 I- 10 - (Repealed Code)
HOUSE BILL - 2459
PASSED - Regular Session

HB2459 SUB ENR  (Uploaded - 05/05/2017)
Relating to regulation of health care and the certificate of need process
§16 - 45 - 3 - (Amended Code)
§16 - 45 - 5 - (Amended Code)
HOUSE BILL - 2520
PASSED - Regular Session

HB2520 SUB ENR  (Uploaded - 04/14/2017)
Prohibiting the use of a tanning device by a person under the age of eighteen
§16 - 5 V- 13 - (Amended Code)
HOUSE BILL - 2586
PASSED - Regular Session

HB2586 SUB ENR  (Uploaded - 04/04/2017)
Relating to required minimum distribution of retirement benefits of plans administered by the Consolidated Public Retirement Board
§16 - 5 T- 1 - (New Code)
§16 - 5 T- 2 - (New Code)
§16 - 5 T- 3 - (New Code)
§16 - 5 T- 4 - (New Code)
§16 - 5 T- 5 - (New Code)
HOUSE BILL - 2620
PASSED - Regular Session

HB2620 SUB ENR  (Uploaded - 04/14/2017)
West Virginia Drug Overdose Monitoring Act
§16 - 12 - 11 - (Amended Code)
§16 - 13 - 3 - (Amended Code)
§16 - 13 A- 7 - (Amended Code)
HOUSE BILL - 2897
PASSED - Regular Session

HB2897 SUB ENR  (Uploaded - 04/14/2017)
Raising the amount required for competitive bidding of construction contracts by the state and its subdivisions
§16 - 13 A- 8 - (Amended Code)
§16 - 13 A- 9 - (Amended Code)
HOUSE BILL - 3096
PASSED - Regular Session

HB3096 SUB ENR  (Uploaded - 04/14/2017)
Relating to operation and regulation of certain water and sewer utilities owned or operated by political subdivisions of the state
§16 - 2 D- 11 - (Amended Code)
§16 - 29 B- 3 - (Amended Code)
§16 - 29 B- 8 - (Amended Code)
§16 - 29 B- 24 - (New Code)
§16 - 29 B- 25 - (New Code)
HOUSE BILL - 117
PASSED - 1st Special Session

HB117 SUB ENR  (Uploaded - 06/16/2017)
Relating to West Virginia Health Care Authority
§16 - 5 - 19 - (Amended Code)
SENATE BILL - 1014
PASSED - 1st Special Session

sb1014 enr  (Uploaded - 06/13/2017)
Relating generally to physician assistants
§16 - 29 B- 1 - (Amended Code)
§16 - 29 B- 10 - (Amended Code)
§16 - 29 B- 19 - (Repealed Code)
§16 - 29 B- 19 A - (Repealed Code)
§16 - 29 B- 20 - (Repealed Code)
§16 - 29 B- 20 A - (Repealed Code)
§16 - 29 B- 21 - (Repealed Code)
§16 - 29 B- 21 A - (Repealed Code)
§16 - 29 B- 27 - (Amended Code)
SENATE BILL - 68
PASSED - Regular Session

SB68 SUB1 ENR  (Uploaded - 03/09/2016)
Disallowing Health Care Authority to conduct rate review and set rates for hospitals
§16 - 4 F- 1 - (New Code)
§16 - 4 F- 2 - (New Code)
§16 - 4 F- 3 - (New Code)
§16 - 4 F- 4 - (New Code)
§16 - 4 F- 5 - (New Code)
SENATE BILL - 123
PASSED - Regular Session

SB123 ENR  (Uploaded - 02/17/2016)
Treatment for sexually transmitted diseases
§16 - 3 C- 2 - (Amended Code)
§16 - 4 - 19 - (Amended Code)
SENATE BILL - 404
PASSED - Regular Session

SB404 SUB1 ENR  (Uploaded - 03/23/2016)
Removing prohibition on billing persons for testing for HIV and sexually transmitted diseases
§16 - 51 - 1 - (New Code)
§16 - 51 - 2 - (New Code)
§16 - 51 - 3 - (New Code)
§16 - 51 - 4 - (New Code)
§16 - 51 - 5 - (New Code)
§16 - 51 - 6 - (New Code)
§16 - 51 - 7 - (New Code)
§16 - 51 - 8 - (New Code)
SENATE BILL - 416
PASSED - Regular Session

SB416 ENR  (Uploaded - 03/11/2016)
Allowing terminally ill patients access to investigational products
§16 - 46 - 3 - (Amended Code)
§16 - 46 - 3 A - (New Code)
§16 - 46 - 5 - (Amended Code)
§16 - 46 - 6 - (Amended Code)
SENATE BILL - 431
PASSED - Regular Session

SB431 enr  (Uploaded - 03/18/2016)
Authorizing pharmacists and pharmacy interns dispense opioid antagonists
§16 - 1 - 4 - (Amended Code)
§16 - 5 Y- 1 - (New Code)
§16 - 5 Y- 2 - (New Code)
§16 - 5 Y- 3 - (New Code)
§16 - 5 Y- 4 - (New Code)
§16 - 5 Y- 5 - (New Code)
§16 - 5 Y- 6 - (New Code)
§16 - 5 Y- 7 - (New Code)
§16 - 5 Y- 8 - (New Code)
§16 - 5 Y- 9 - (New Code)
§16 - 5 Y- 10 - (New Code)
§16 - 5 Y- 11 - (New Code)
§16 - 5 Y- 12 - (New Code)
§16 - 5 Y- 13 - (New Code)
SENATE BILL - 454
PASSED - Regular Session

SB454 SUB2 ENR  (Uploaded - 03/23/2016)
Licensing and regulating medication-assisted treatment programs for substance use disorders
§16 - 32 - 2 - (Amended Code)
§16 - 32 - 11 - (Amended Code)
SENATE BILL - 545
PASSED - Regular Session

SB545 SUB1 ENR  (Uploaded - 03/15/2016)
Relating to asbestos abatement on oil and gas pipelines
§16 - 5 V- 2 - (Amended Code)
SENATE BILL - 563
PASSED - Regular Session

SB563 ENR  (Uploaded - 03/15/2016)
Increasing retirement benefit multiplier for WV Emergency Medical Services Retirement System members
§16 - 29 B- 26 - (Amended Code)
§16 - 29 B- 28 - (New Code)
§16 - 29 B- 29 - (New Code)
SENATE BILL - 597
PASSED - Regular Session

SB597 SUB1 ENR  (Uploaded - 03/17/2016)
Relating generally to Health Care Authority
§16 - 1 - 9 C - (Amended Code)
SENATE BILL - 625
PASSED - Regular Session

SB625 SUB1 ENR  (Uploaded - 03/15/2016)
Revising exceptions from FOIA provided for in Aboveground Storage Tank Act
§16 - 5 - 19 - (Amended Code)
HOUSE BILL - 4334
PASSED - Regular Session

hb4334 ENR  (Uploaded - 03/17/2016)
Clarifying the requirements for a license to practice as an advanced practice registered nurse and expanding prescriptive authority
§16 - 2 D- 1 - (Amended Code)
§16 - 2 D- 2 - (Amended Code)
§16 - 2 D- 3 - (Amended Code)
§16 - 2 D- 4 - (Amended Code)
§16 - 2 D- 4 A - (Repealed Code)
§16 - 2 D- 4 B - (Repealed Code)
§16 - 2 D- 5 - (Amended Code)
§16 - 2 D- 5 A - (Repealed Code)
§16 - 2 D- 5 B - (Repealed Code)
§16 - 2 D- 5 C - (Repealed Code)
§16 - 2 D- 5 D - (Repealed Code)
§16 - 2 D- 5 E - (Repealed Code)
§16 - 2 D- 6 - (Amended Code)
§16 - 2 D- 7 - (Amended Code)
§16 - 2 D- 7 A - (Repealed Code)
§16 - 2 D- 8 - (Amended Code)
§16 - 2 D- 9 - (Amended Code)
§16 - 2 D- 10 - (Amended Code)
§16 - 2 D- 11 - (Amended Code)
§16 - 2 D- 12 - (Amended Code)
§16 - 2 D- 13 - (Amended Code)
§16 - 2 D- 14 - (Amended Code)
§16 - 2 D- 15 - (Amended Code)
§16 - 2 D- 16 - (New Code)
§16 - 2 D- 17 - (New Code)
§16 - 2 D- 18 - (New Code)
§16 - 2 D- 19 - (New Code)
§16 - 2 D- 20 - (New Code)
HOUSE BILL - 4365
PASSED - Regular Session

HB4365 SUB ENR  (Uploaded - 03/16/2016)
Relating to the certificate of need process
§16 - 5 B- 18 - (New Code)
HOUSE BILL - 4388
PASSED - Regular Session

HB4388 SUB ENR  (Uploaded - 03/17/2016)
Relating to stroke centers
§16 - 5 G- 2 - (Amended Code)
§16 - 5 G- 4 - (Amended Code)
HOUSE BILL - 4520
PASSED - Regular Session

HB4520 SUB ENR  (Uploaded - 03/09/2016)
Clarifying that certain hospitals have only one governing body whose meetings shall be open to the public
§16 - 5 H- 2 - (Amended Code)
§16 - 5 H- 5 - (Amended Code)
§16 - 5 H- 7 - (Amended Code)
HOUSE BILL - 4537
PASSED - Regular Session

HB4537 SUB ENR  (Uploaded - 03/23/2016)
Relating to the regulation of chronic pain clinics
§16 - 2 - 11 - (Amended Code)
HOUSE BILL - 4659
PASSED - Regular Session

HB4659 SUB ENR  (Uploaded - 03/16/2016)
Authorizing local health departments to bill health insurance plans for services
§16 - 4 C- 6 C - (Amended Code)
HOUSE BILL - 4726
PASSED - Regular Session

hb4726 ENR  (Uploaded - 03/11/2016)
Relating to coal mining generally
This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  |  Terms of Use  |   Web Administrator   |   © 2017 West Virginia Legislature ***